Based on 3,746,423,788 shares issued and outstanding as of May 14,2021
Title of Class Name and Address of Beneficial Owner Amount and Nature of Beneficial Ownership Percentage
Common David R. Koos 2466568 0.07 %
c/o Regen Biopharma, Inc
4700 Spring Street, Suite 304,
La Mesa, California 91942*
All Officers and Directors as a Group 2466568 0.07 %
* includes 3104 shares held by BMXP Holdings Shareholder's Business Trust and 705 shares held by the AFN Trust
Based on 414,147,858 shares issued and outstanding as of May 25,2021
Title of Class Name and Address of Beneficial Owner Amount and Nature of Beneficial Ownership Percentage
Series A Preferred David R. Koos 197788998 4.7 %
c/o Regen Biopharma, Inc
4700 Spring Street, Suite 304,
La Mesa, California 91942*
Zander Therapeutics, Inc. 197785714 4.7 %
All Officers and Directors as a Group 197788988 4.7 %
* includes 316 shares held by BMXP Holdings Shareholder's Business Trust and 71 shares held by the AFN Trust and 197785714 shares held by Zander Therapeutics, Inc. both of which are controlled by David Koos.
Based on 44,000,000 shares issued and outstanding as of 5/25/2021
Title of Class Name and Address of Beneficial Owner Amount and Nature of Beneficial Ownership Percentage
Series M Preferred David R. Koos 11500000 26.14 %
c/o Regen Biopharma, Inc
4700 Spring Street, Suite 304,
La Mesa, California 91942
Series M Preferred Todd S. Caven 10000000 22.73 %
8578 TERRACEVIEW LANE NORTH
MAPLE GROVE, MN 55311
Series M Preferred Roger Formisano 3000000 6.82 %
4124 N. 64th Street
Scottsdale, AZ 85251
Series M Preferred Robert D. Hopkins 3000000 6.82 %
11642 N. 40th Place
Phoenix, AZ 85028
Series M Preferred Harry Lander 10000000 22.73 %
50 SUTTON PLACE SOUTH
APT. 6A
NEW YORK, NY 10022
Series M Preferred Jean-Pierre Millon 6000000 0.136364
3908 E. San Miguel Ave
Paradise Valley, AZ 85253
All Officers and Directors as a Group 11500000 26.14 %
Based on 50,000 shares issued and outstanding as of May 25, 2021
Title of Class Name and Address of Beneficial Owner Amount and Nature of Beneficial Ownership Percentage
Series AA Preferred David R. Koos 50000 100 %
c/o Regen Biopharma, Inc
4700 Spring Street, Suite 304,
La Mesa, California 91942
All Officers and Directors as a Group 50000 100 %
Based on 10,000 shares issued and outstanding as of May 25, 2021
Title of Class Name and Address of Beneficial Owner Amount and Nature of Beneficial Ownership Percentage
Series NC Preferred David R. Koos 10000 100 %
c/o Regen Biopharma, Inc
4700 Spring Street, Suite 304,
La Mesa, California 91942
All Officers and Directors as a Group 10000 100 %
AI
